Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets close in 3 hrs 10 mins

S&P 500
5,902.70
+9.08(+0.15%)
Dow 30
43,251.87
-137.73(-0.32%)
Nasdaq
18,894.88
+103.07(+0.55%)
Russell 2000
2,314.39
+8.05(+0.35%)
Crude Oil
69.39
+0.23(+0.33%)
Gold
2,634.10
+19.50(+0.75%)

Sedana Medical AB (publ) (7D2A.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Follow

0.8930

-0.0100

(-1.11%)

As of 09:15AM CET. Market open.

Currency in EUR

Valuation Measures⁴

Market Cap (intraday)	91.80M
Enterprise Value	72.87M
Trailing P/E	N/A
Forward P/E	1.11k
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	5.96
Price/Book (mrq)	1.09
Enterprise Value/Revenue	4.85
Enterprise Value/EBITDA	-2.65

Trading Information

Stock Price History

Beta (5Y Monthly)	0.42
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	2.3900
52 Week Low ³	0.8930
50-Day Moving Average ³	1.6640
200-Day Moving Average ³	1.7633

Share Statistics

Avg Vol (3 month) ³	3.26k
Avg Vol (10 day) ³	400
Shares Outstanding ⁵	99.34M
Implied Shares Outstanding ⁶	N/A
Float ⁸	67.6M
% Held by Insiders ¹	25.33%
% Held by Institutions ¹	52.89%
Shares Short ⁴	N/A
Short Ratio ⁴	N/A
Short % of Float ⁴	N/A
Short % of Shares Outstanding ⁴	N/A
Shares Short (prior month ) ⁴	N/A

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Currency in SEK.

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	-32.87%
Operating Margin (ttm)	-36.47%

Management Effectiveness

Return on Assets (ttm)	-3.27%
Return on Equity (ttm)	-5.85%

Income Statement

Revenue (ttm)	174.14M
Revenue Per Share (ttm)	1.75
Quarterly Revenue Growth (yoy)	16.00%
Gross Profit (ttm)	N/A
EBITDA	-52M
Net Income Avi to Common (ttm)	-57.24M
Diluted EPS (ttm)	-0.0500
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	226.39M
Total Cash Per Share (mrq)	2.28
Total Debt (mrq)	7.24M
Total Debt/Equity (mrq)	0.76
Current Ratio (mrq)	6.91
Book Value Per Share (mrq)	9.56

Cash Flow Statement

Operating Cash Flow (ttm)	-10.27M
Levered Free Cash Flow (ttm)	-200.95M